HEALTHEURACTIV
Greece risks losing access to 60% of new medicines, drugmakers warn [Advocacy Lab]
Greece risks losing access to 60% of new medicines as pharmaceutical companies may downgrade the country in strategic priorities, according to a trade group's head.
Related Signal
Adjacent reporting
- AstraZeneca chief warns group could withhold new drugs in Europe
- Japan risks losing out without drug pricing reform, warns AstraZeneca CEO
- China's control over UK's antibiotics supply 'leaves Britain vulnerable', report warns
- STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
- What medications are at risk as Strait of Hormuz blockade threatens supply chain